Variant report
Variant | nsv962031 |
---|---|
Chromosome Location | chr2:50774027-50776819 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs559647614 | chr2:50774027-50774028 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs529808857 | chr2:50774051-50774052 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs547948164 | chr2:50774069-50774070 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs138717688 | chr2:50774088-50774089 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs10175903 | chr2:50774094-50774095 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs527422056 | chr2:50774103-50774104 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs114448604 | chr2:50774127-50774128 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs189373078 | chr2:50774152-50774153 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs557158432 | chr2:50774153-50774154 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs142880365 | chr2:50774157-50774158 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs188683590 | chr2:50774198-50774199 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs181459450 | chr2:50774213-50774214 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs529868123 | chr2:50774219-50774220 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs550011446 | chr2:50774229-50774230 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs546783237 | chr2:50774236-50774237 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs74995522 | chr2:50774279-50774280 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs559580083 | chr2:50774304-50774305 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs527294994 | chr2:50774323-50774324 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs554798407 | chr2:50774324-50774325 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs72835366 | chr2:50774348-50774349 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs141290661 | chr2:50774357-50774358 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs558945831 | chr2:50774376-50774377 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs186495314 | chr2:50774411-50774412 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs71404963 | chr2:50774436-50774437 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs67276499 | chr2:50774437-50774438 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs386390167 | chr2:50774444-50774445 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs34901935 | chr2:50774456-50774457 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs60213629 | chr2:50774459-50774460 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs565827823 | chr2:50774508-50774509 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs150765517 | chr2:50774524-50774525 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs553551829 | chr2:50774527-50774528 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs2058750 | chr2:50774582-50774583 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs542396236 | chr2:50774592-50774593 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs563085748 | chr2:50774639-50774640 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs530520761 | chr2:50774651-50774652 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs111764462 | chr2:50774705-50774706 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs76479855 | chr2:50774748-50774749 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs549881704 | chr2:50774785-50774786 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs569889036 | chr2:50774803-50774804 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs72882091 | chr2:50774810-50774811 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs546550939 | chr2:50774820-50774821 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs6707344 | chr2:50774874-50774875 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs529116831 | chr2:50774882-50774883 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs77482356 | chr2:50774892-50774893 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs548405783 | chr2:50774905-50774906 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs570166171 | chr2:50774915-50774916 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs532313300 | chr2:50774946-50774947 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs537501482 | chr2:50774955-50774956 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs559004966 | chr2:50774991-50774992 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs570828734 | chr2:50775033-50775034 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Cognitive impairment | 21505072 | CNVD |
Psychiatric disorder | 19734545 | CNVD |
Autism | 20844286 | CNVD |
Schizophrenia | 20838587 | CNVD |
Schizophrenia | 20718829 | CNVD |
Autism | 19218893 | CNVD |
Autism | 22209245 | CNVD |
Neuropsychiatric disorder | 21827697 | CNVD |
Schizophrenia | 22118685 | CNVD |
Autism | 20663923 | CNVD |
Schizophrenia | 21285140 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21990379 | CNVD |
Schizophrenia | 22885689 | CNVD |
Autism | 20964600 | CNVD |
Schizophrenia | 19521646 | CNVD |
Attention deficit hyperactivity disorder | 22214315 | CNVD |
Chronic motor tic disorder | 22214315 | CNVD |
Schizophrenia | 22214315 | CNVD |
Mental retardation | 19896112 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:50759800-50777400 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr2:50766200-50791800 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
3 | chr2:50773200-50775400 | Enhancers | HMEC | breast |
4 | chr2:50773400-50775400 | Enhancers | NHEK | skin |
5 | chr2:50773600-50774800 | Enhancers | Pancreatic Islets | Pancreatic Islet |
6 | chr2:50773600-50778600 | Weak transcription | Fetal Heart | heart |
7 | chr2:50774000-50774200 | Enhancers | Brain Germinal Matrix | brain |
8 | chr2:50774000-50775600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
9 | chr2:50774200-50775400 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
10 | chr2:50774200-50775400 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
11 | chr2:50774200-50779000 | Weak transcription | Brain Germinal Matrix | brain |
12 | chr2:50774400-50775400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
13 | chr2:50774600-50775000 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
14 | chr2:50774800-50775200 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |